X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (400) 400
humans (379) 379
clinical neurology (303) 303
male (302) 302
female (281) 281
aged (267) 267
dementia (265) 265
psychiatry (199) 199
neurosciences (162) 162
alzheimers-disease (161) 161
aged, 80 and over (143) 143
parkinson's disease (142) 142
alzheimer's disease (128) 128
middle aged (124) 124
geriatrics & gerontology (119) 119
neuropsychological tests (85) 85
prevalence (84) 84
diagnosis (83) 83
neurology (82) 82
lewy bodies (81) 81
parkinson disease - complications (81) 81
depression (80) 80
abridged index medicus (66) 66
adult (65) 65
risk factors (64) 64
research (62) 62
dementia with lewy bodies (61) 61
mild cognitive impairment (61) 61
parkinsons-disease (59) 59
cognitive impairment (57) 57
parkinson disease - psychology (56) 56
gerontology (55) 55
pathology (51) 51
mental disorders (48) 48
parkinsons disease (45) 45
symptoms (45) 45
cognitive ability (44) 44
surgery (44) 44
parkinson disease - diagnosis (43) 43
alzheimers disease (42) 42
analysis (42) 42
cognition (42) 42
parkinson disease - epidemiology (42) 42
care and treatment (41) 41
severity of illness index (41) 41
dementia disorders (40) 40
medicin och hälsovetenskap (39) 39
neurodegenerative diseases (39) 39
impairment (38) 38
prospective studies (38) 38
cohort studies (37) 37
follow-up studies (37) 37
norway (37) 37
biomarkers (36) 36
klinisk medicin (36) 36
risk (36) 36
dementia - complications (35) 35
dementia - psychology (35) 35
medical and health sciences (34) 34
mortality (34) 34
alpha-synuclein (33) 33
cross-sectional studies (33) 33
biochemistry & molecular biology (32) 32
dementia - diagnosis (32) 32
medical research (32) 32
psychiatric status rating scales (32) 32
visual hallucinations (32) 32
brain (31) 31
cerebrospinal fluid (31) 31
clinical medicine (31) 31
clinical trials (31) 31
internal medicine (31) 31
lewy body disease - diagnosis (31) 31
longitudinal studies (30) 30
original research article (30) 30
age (29) 29
alzheimer disease - diagnosis (29) 29
cognition disorders - etiology (29) 29
diagnostic-criteria (29) 29
geriatrics (29) 29
lewy body dementia (29) 29
magnetic resonance imaging (28) 28
parkinson disease - physiopathology (28) 28
psychosis (28) 28
rivastigmine (28) 28
treatment outcome (28) 28
alzheimer disease - psychology (27) 27
health aspects (27) 27
neurologi (27) 27
neuropsychiatric symptoms (27) 27
nursing homes (27) 27
parkinson disease - pathology (27) 27
studies (27) 27
double-blind method (26) 26
norway - epidemiology (26) 26
scale (26) 26
biology (25) 25
dementia - drug therapy (25) 25
disease progression (25) 25
dlb (25) 25
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Pathology, ISSN 1015-6305, 01/2019, Volume 29, Issue 1, pp. 63 - 74
Alzheimer's disease ( AD ) is characterized by accumulation of β‐amyloid plaques ( AP ) and neurofibrillary tangles ( NFT ) in the cortex, together with... 
cathepsin D | neurofibrillary degeneration | Alzheimer's disease | lysosome | Lewy body dementia | DEMENTIA | TAU | AMYLOID PRECURSOR PROTEIN | ALPHA-SYNUCLEIN | PATHOLOGY | A-BETA-DEPOSITION | PROCATHEPSIN-D | NEUROSCIENCES | CLINICAL NEUROLOGY | NEUROPATHOLOGIC ASSESSMENT | PARKINSON-DISEASE | CELL-CYCLE | LEWY BODIES | Neurons - pathology | Cathepsin D - physiology | Neocortex - physiology | Plaque, Amyloid - pathology | Humans | Lewy Body Disease - pathology | tau Proteins - metabolism | Male | Cathepsin D - metabolism | Alzheimer Disease - pathology | Parietal Lobe - pathology | Neocortex - metabolism | Neurodegenerative Diseases - physiopathology | Neurofibrillary Tangles - metabolism | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Cathepsin D - genetics | Aged, 80 and over | Biomarkers | Female | Aged | Temporal Lobe - pathology | Lewy Bodies - pathology | alpha-Synuclein - metabolism | Brain | Parkinson's disease | Peptides | Inclusions | Synuclein | Cortex (parietal) | Proteolysis | Neurodegeneration | Dementia disorders | Amyloid | Cathepsin D | Degeneration | Plaques | Movement disorders | Cortex (temporal) | Neurodegenerative diseases | Cortex | Lewy bodies | Brodmann's area | Neurofibrillary tangles | Tau protein | Correlation analysis | Alzheimers disease | Dementia | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, pp. e43228 - e43228
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Bosch, Jackie and Gerstein, Hertzel C and Dagenais, Gilles R and Díaz, Rafael and Dyal, Leanne and Jung, Hyejung and Maggiono, Aldo P and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, Leanne and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | EVENTS | MYOCARDIAL-INFARCTION | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article